THE ROLE OF ACTIVATION OF THE SYMPATHETIC NERVOUS SYSTEM IN THE PATHOGENESIS OF ARTERIAL HYPERTENSION AND THE CHOICE OF A METHOD FOR THE TREATMENT OF ARTERIAL HYPERTENSION
https://doi.org/10.38109/2225-1685-2018-3-88-94
Abstract
The basis for the successful treatment of any disease is a clear understanding of its cause, the mechanisms of its development, and their relationship to symptoms. The article considers one of the links in the pathogenesis of arterial hypertension - an increase in the activity of the sympathetic nervous system, describes the main methods for detecting hypersympathicotonia, approaches to the selection of drug therapy.
About the Authors
A. V. Rozanov
Pirogov Russian National Research Medical University (RNRMU), Russian gerontological scientific and clinical center
Russian Federation
Russian Federation
Candidate of Medical Sciences, Senior Researcher of the Laboratory of Cardiovascular Aging.
Tel. +7 499 187-64-67
Ostrovitianov str. 1, Moscow, Russia, 117997
Yu. V. Kotovskaya
Pirogov Russian National Research Medical University (RNRMU), Russian gerontological scientific and clinical center
Russian Federation
Russian Federation
Doctor of Medical Sciences, Professor, deputy director for scientific work.
Tel.+7 499 187-64-67
O. N. Tkacheva
Pirogov Russian National Research Medical University (RNRMU), Russian gerontological scientific and clinical center
Russian Federation
Russian Federation
Doctor of Medical Sciences, Professor. director.
Tel. +7 499 187-64-67
References
1. WHO. A global brief on hypertension. 2013. http://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension/en/
2. Boitsov SA, BalanovaYu. A., Shalnova SA, etc. Arterial hypertension among persons aged 25-64 years: prevalence, awareness, treatment and control. Based on the materials of the ESSE study. Cardiovascular therapy and prevention 2014; 13 (4): 4-14 [in Russian]
3. ParatiG., EslerM. Thehumansympatheticnervoussystem: itsre levanceinhypertensionandheartfailure. Eur Heart J 2012;33 (9):1058–1066.
4. Bhatt DL, Kandzari DE, O'Neill WW et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370: 1393–401.
5. Williams B, Mancia G., Spiering W., Rosei EA et al., 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018;39(33):3021–3104
6. VA Grigin, NM Danilov, OVSagaidak, GV Shchelkova and others. Methods for assessing sympathetic activity in patients with refractory systemic hypertension.Systemic hypertension. 2014; 4: 21-26 [in Russian]
7. Makarov LM Holter monitoring.Medpraktika-M.2017 [in Russian]
8. Nur-Mammadova G.; Mustafayev, I. Study of influence of bisoprolol, nebivolol and carvedilol on the heart rate variability in men with arterial hypertension Journal of Hypertension. 2015;33:e-Supple:e-195.
9. Pousset F1, Copie X, Lechat P, Jaillon P et al. Effects of bisoprolol on heart rate variability in heart failure. Am J Cardiol. 1996:15;77(8):612-7.
Review
For citations:
Rozanov A.V., Kotovskaya Yu.V., Tkacheva O.N. THE ROLE OF ACTIVATION OF THE SYMPATHETIC NERVOUS SYSTEM IN THE PATHOGENESIS OF ARTERIAL HYPERTENSION AND THE CHOICE OF A METHOD FOR THE TREATMENT OF ARTERIAL HYPERTENSION. Eurasian heart journal. 2018;(3):88-94. https://doi.org/10.38109/2225-1685-2018-3-88-94
Views:
1416
Email this article 
